Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015:16:514.
doi: 10.1186/s10194-015-0514-8. Epub 2015 Apr 1.

Efficacy of frovatriptan as compared to other triptans in migraine with aura

Stefan Evers  1 , Lidia Savi, Stefano Omboni, Carlo Lisotto, Giorgio Zanchin, Lorenzo Pinessi
Affiliations
Meta-Analysis

Efficacy of frovatriptan as compared to other triptans in migraine with aura

Stefan Evers et al. J Headache Pain. 2015.

Abstract

Background: The treatment of migraine attacks with aura by triptans is difficult since triptans most probably are not efficacious when taken during the aura phase. Moreover, there are insufficient data from randomised studies whether triptans are efficacious in migraine attacks with aura when taken during the headache phase. In this metaanalysis, we aimed to compare the efficacy of frovatriptan versus rizatriptan, zolmitriptan, and almotriptan.

Methods: Five double-blind, randomized, controlled crossover trials were pooled. All trials had an identical design. Patients were asked to treat three consecutive migraine attacks with frovatriptan 2.5 mg and three consecutive migraine attacks with a comparative triptan (rizatriptan 10 mg; zomitriptan 2.5 mg; almotriptan 12.5 mg).

Results: In this analysis, 117 migraine attacks with aura could be included (intention-to-treat population). The mean headache intensity after 2 hours was 1.2 +/- 1.0 for frovatriptan and 1.6 +/- 1.0 for the other triptans (p<0.05); all triptans showed significant improvement of headache. Frovatriptan resulted in significantly lower relapse rates at 24 hours and 48 hours when taken in migraine attacks with aura.

Conclusions: Our data suggest that frovatriptan is efficacious and even superior in some endpoints also when taken during the headache phase in migraine attacks with aura. This is of particular importance for those many patients who have migraine attacks both without and with aura.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean headache intensity 1 during attack treatment for all four different triptans. Statistical comparison by ANOVA, for post-hoc analysis see text. 1Headache intensity graded as 0 = none; 1 = mild; 2 = moderate; 3 = severe.
See this image and copyright information in PMC

References

    1. Bates D, Ashford E, Dawson R, Ensink FB, Gilhus NE, Olesen J, Pilgrim AJ, Shevlin P. Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group. Neurology. 1994;44:1587–1592. doi: 10.1212/WNL.44.9.1587. - DOI - PubMed
    1. Dowson A. Can oral 311C90, a novel 5-HT1D agonist, prevent migraine headache when taken during an aura? Eur Neurol. 1996;36(Suppl 2):28–31. doi: 10.1159/000119101. - DOI - PubMed
    1. Olesen J, Diener HC, Schoenen J, Hettiarachchi J. No effect of eletriptan administration during the aura phase of migraine. Eur J Neurol. 2004;11:671–677. doi: 10.1111/j.1468-1331.2004.00914.x. - DOI - PubMed
    1. Aurora SK, Barrodale PM, McDonald SA, Jakubowski M, Burstein R. Revisiting the efficacy of sumatriptan therapy during the aura phase of migraine. Headache. 2009;49:1001–1004. doi: 10.1111/j.1526-4610.2009.01429.x. - DOI - PMC - PubMed
    1. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor P. EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force. Eur J Neurol. 2009;16:968–981. doi: 10.1111/j.1468-1331.2009.02748.x. - DOI - PubMed

Publication types

LinkOut - more resources